chevron_leftBack
As of 15 June 2026, Jiangsu Bioperfectus Technologies Co., Ltd. has a market cap of $751.33M USD, ranking #12469 globally and #3719 in China.
It ranks #1140 in the Healthcare sector, and #423 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$751.33MUSD
5.09B CNY
Enterprise Value
$574.49MUSD
3.89B CNY
Revenue (TTM)
$50.04MUSD
339.05M CNY
EBITDA (TTM)
-$1.27MUSD
-8.61M CNY
Net Income (TTM)
-$6.06MUSD
-41.08M CNY
EBITDA Margin
-2.5%
Profit Margin
-12%
PS Ratio
15.0
PB Ratio
1.7
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Guoqiang Wang
open_in_new
Employees
586
Founded
2010
Website
s-sbio.com
open_in_new
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 1.7% | -2.4% | 9.2% | -17% | -23% | 37% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
688399
江苏硕世生物科技股份有限公司 Class A
ISIN: CNE1000055B2
Shares Out.:
Shares Outstanding:
83.872M1
Shares Float:
83.868M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
61.75 CNY |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Jiangsu Bioperfectus Technologies Co., Ltd.
Jiangsu Bioperfectus Technologies Co., Ltd., a molecular diagnostic company, engages in the research, development, production, and sale of in vitro diagnostic products in China. The company offers in vitro diagnostic reagents and supporting testing equipment, as well as in vitro testing services. It also provides HPV and cervical cancer testing services, respiratory infection detection solution, solutions for infectious diarrhea, and STI detection solution for reproductive tract infections. Jiangsu Bioperfectus Technologies Co., Ltd. was founded in 2010 and is headquartered in Taizhou, China.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SSE: 600276
|
$53.85B
7K%
364.89B CNY
|
44.9
|
|
SSE: 603259
|
$49.64B
7K%
336.36B CNY
|
17.2
|
|
SHEK: 3692
|
$28.52B
4K%
223.48B HKD
|
35.7
|
|
SHEK: 1801
|
$18.8B
2K%
147.32B HKD
|
162.3
|
|
SSE: 688506
|
$16.51B
2K%
111.89B CNY
|
-
|
|
SHEK: 9926
|
$16.01B
2K%
125.46B HKD
|
-
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
101K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
73K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
48K%
|
97.4
|
|
SIX: RO
|
$321.52B
43K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
38K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
36K%
218.9B CHF
|
20.5
|
chevron_leftBack